1. Output analysis of AMR EU funding 5FP-6FP-7FP -Quantitative data- Coordinators of 117 AMR-related EU projects contacted, yielding 54 submissions Survey was open between August 1 and September 10, 2013 Questionnaire designed by SAB members Herman Goossens and Stephan Harbarth together with Arjon van Hengel (EC) and the JPIAMR secretariat

2. 1. Yes36 (67%) 2. No18 (33%) Research Activities Has the project finished?

3. 1. Basic research25 (46%) 2. Drug discovery/development of novel antibiotics 15 (28%) 3. Treatment of AMR infections5 (9%) 4. Prevention of AMR infections8 (15%) 5. Clinical trials (observational and intervention) 10 (19%) 6. Transmission dynamics6 (11%) 7. Diagnostic tools13 (24%) 8. Antibiotic resistance surveillance 11 (20%) 9. Environmental aspects (drug pollution, reservoir function, transfer etc) 2 (4%) 10. Other (e.g. Molecular studies of AMR bacteria, antibiotic stewardship, immunology, pathogenicity, animal models…) 11 (20%) Research Activities What was the main research activity of the project? OTHER "Prevention of healthcare-associated infections" (walter.zingg@hcuge.ch) "animal models" (eag@ceh.ac.uk) "molecular studies, pathogenicity" (christian.brun-buisson@hmn.ap-hop-paris.fr) "Risk Assessment" (hcw@dfvf.dk) "Evolution and spread of antibiotic resistant bacteria and their resistance genes" (rwillems@umcutrecht.nl) "(Re)development of old antibiotics" (jwmouton@gmail.com) "economics of resistance" (Katherine.Loens@uza.be) "epidemiology, pathogenicity, virulence strategies of Streptococcus pneumoniae" (gsc@helmholtz-hzi.de) "pathogenicity" (birgitta.henriques@ki.se) "Molecular studies of AMR bacteria" (sfhvmiw@ucl.ac.uk)

4. How many peer reviewed publications have resulted from the project? Research Activities Number of peer-reviewed publications (from 50 replies): TOTAL: 1784 AVERAGE:35,7 MEDIAN:20,5 MAXIMUM:176

5. 1. Cooperation based on EU funding 25 (47%) 2. Cooperation based on national funding 4 (8%) 3. Cooperation without collaborative funding 2 (4%) 4. No previous cooperation16 (30%) 5. Other6 (11%) Research consortium Was/is the consortium, or a subset of it, a continuation of a previous cooperation? If yes, please indicate the kind of cooperation. If not applicable to your project, please specify "other" OTHER "Limited collaboration between some partners" (a.i.zumla@gmail.com) "ERC young investigator award" (f.balloux@ucl.ac.uk) "Collaboration within the ESDPP " (evelyne.jacqz-aigrain@rdb.aphp.fr) "I sdo not understand the context of this questions" (adriacell@adriacell.com)

6. 1. Cooperation based on follow- up EU funding 17 (32%) 2. Cooperation based on national funding 7 (13%) 3. Cooperation without collaborative funding 15 (28%) 4. No continued cooperation5 (9%) 5. Other9 (17%) Research consortium Did/will the consortium, or a subset of it, continue to operate after the end of the project? If so, please indicate how. If not applicable to your project, please specify "other". OTHER "Not applicable" (a.i.zumla@gmail.com) "not applicable" (f.schellevis@nivel.nl) "Cooperation based on available funding" (eag@ceh.ac.uk) "N/A" (f.balloux@ucl.ac.uk) "will be decided in 2015" (karin.thevissen@biw.kuleuven.be) "to early to say, but projects as a spin-off have already emerged." (jwmouton@gmail.com) "no relevant program found" (adriacell@adriacell.com) "Not finished" (john.wallace@abdn.ac.uk)

7. How many new jobs (approximately) did your project generate (for early stage researchers (pre-doctoral level), post- doctoral research fellows or technicians)? (not including permanent personnel that were employed prior to the EU contract). Employment and career progression Number of new jobs (from 50 replies): TOTAL: 836 AVERAGE:16,72

8. 1. Yes47 (92%) 2. No4 (8%) Employment and career progression Has the research work on this grant played a key role in any qualifications gained by the researchers involved in the project?

9. 1. Yes39 (76%) 2. No12 (24%) Industrial partners Did your consortium include industrial partners? Number of industrial partners: TOTAL: 118 AVERAGE (if ”Yes”):3,03 AVERAGE for all 51 replies:2,31

10. 1. Research28 (70%) 2. R&D service provider (e.g. technology development, GMP production) 26 (65%) 3. Training1 (2%) 4. Administration/Management5 (12%) 5. Communication/Dissemination 9 (22%) 6. Other2 (5%) Industrial partners If your consortium included industrial partners, please specify within what area they were involved. OTHER "3 hard working SMEs/2 Universities working somehow more relaxed" (adriacell@adriacell.com) "Development of vaccine" (gsc@helmholtz-hzi.de)